Tacke M - Search Results

1

Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).

Fülster S, Tacke M, Sandek A, Ebner N, Tschöpe C, Doehner W, Anker SD, von Haehling S. Fülster S, et al. Among authors: tacke m. Eur Heart J. 2013 Feb;34(7):512-9. doi: 10.1093/eurheartj/ehs381. Epub 2012 Nov 23. Eur Heart J. 2013. PMID: 23178647

2

Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour.

Ebner N, Földes G, Szabo T, Tacke M, Fülster S, Sandek A, Doehner W, Anker SD, von Haehling S. Ebner N, et al. Among authors: tacke m. Clin Res Cardiol. 2013 Feb;102(2):95-101. doi: 10.1007/s00392-012-0499-0. Epub 2012 Aug 10. Clin Res Cardiol. 2013. PMID: 22878732

3

Resting energy expenditure and the effects of muscle wasting in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).

Tacke M, Ebner N, Boschmann M, Jarius A, Valentova M, Fülster S, Sandek A, Schomburg L, Anker SD, Doehner W, von Haehling S. Tacke M, et al. J Am Med Dir Assoc. 2013 Nov;14(11):837-41. doi: 10.1016/j.jamda.2013.08.008. Epub 2013 Oct 2. J Am Med Dir Assoc. 2013. PMID: 24094897

4

The role of the intrinsic FAS pathway in Titanocene Y apoptosis: The mechanism of overcoming multiple drug resistance in malignant leukemia cells.

Kater L, Claffey J, Hogan M, Jesse P, Kater B, Strauss S, Tacke M, Prokop A. Kater L, et al. Among authors: tacke m. Toxicol In Vitro. 2012 Feb;26(1):119-24. doi: 10.1016/j.tiv.2011.09.010. Epub 2011 Oct 1. Toxicol In Vitro. 2012. PMID: 21986259

5

Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay.

Weber H, Claffey J, Hogan M, Pampillón C, Tacke M. Weber H, et al. Among authors: tacke m. Toxicol In Vitro. 2008 Mar;22(2):531-4. doi: 10.1016/j.tiv.2007.09.014. Epub 2007 Sep 29. Toxicol In Vitro. 2008. PMID: 17981007

6

Anticancer activity and mode of action of titanocene C.

Olszewski U, Claffey J, Hogan M, Tacke M, Zeillinger R, Bednarski PJ, Hamilton G. Olszewski U, et al. Among authors: tacke m. Invest New Drugs. 2011 Aug;29(4):607-14. doi: 10.1007/s10637-010-9395-5. Epub 2010 Feb 17. Invest New Drugs. 2011. PMID: 20162321

7

Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.

Cuffe S, Dowling CM, Claffey J, Pampillón C, Hogan M, Fitzpatrick JM, Carty MP, Tacke M, Watson RW. Cuffe S, et al. Among authors: tacke m. Prostate. 2011 Feb 1;71(2):111-24. doi: 10.1002/pros.21227. Prostate. 2011. PMID: 20665530

8

Novel achiral titanocene anti-cancer drugs synthesised from bis-N,N-dimethylamino fulvene and lithiated heterocyclic compounds.

Pampillón C, Claffey J, Hogan M, Tacke M. Pampillón C, et al. Among authors: tacke m. Biometals. 2008 Apr;21(2):197-204. doi: 10.1007/s10534-007-9108-5. Epub 2007 Jul 31. Biometals. 2008. PMID: 17665139

9

Oxali-titanocene Y: a potent anticancer drug.

Claffey J, Hogan M, Müller-Bunz H, Pampillón C, Tacke M. Claffey J, et al. Among authors: tacke m. ChemMedChem. 2008 May;3(5):729-31. doi: 10.1002/cmdc.200700302. ChemMedChem. 2008. PMID: 18186097 No abstract available.

10

Titanocene difluorides with improved cytotoxic activity.

Eger S, Immel TA, Claffey J, Müller-Bunz H, Tacke M, Groth U, Huhn T. Eger S, et al. Among authors: tacke m. Inorg Chem. 2010 Feb 15;49(4):1292-4. doi: 10.1021/ic9022163. Inorg Chem. 2010. PMID: 20055428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page